MHRA alert Archives | Dispensing Doctors' Association

April 25th 2025

Alert: Brilique 90mg Tablets

Dispensary teams are alerted to a spelling error on G Pharma imported Brilique 90mg Tablets. Cartons in three batches misspell the active ingredient as ‘Tricagelor’ rather than ‘Ticagrelor’. The correct spelling of the activ

April 22nd 2025

Alert: lercanidipine HCl 20mg tablets

Recordati Pharmaceuticals Limited is recalling one batch of lercanidipine HCl 20mg tablets The affected batch is Batch No. Expiry Date Pack Size First Distributed MD4L07 01/2028 28 10/04/2025 This is a precau

April 9th 2025

Alert: Synalar Gel 30g and 60g

Seven batches of Synalar Gel 30g and 60g are being recalled in a precautionary measure. This is due to excessive (2ppm) levels of a residual solvent (benzene) 2ppm in some of the affected batches. View the affected batches. Supplier Reig Jofre UK a

Hot topics

DM Zone news HR Zone news Clinical guidance news Political News Scotland Wales Rurality Supply Shortages COVID19

April 8th 2025

Alert: Renacet 475 mg and 950mg film-coated tablets

RenaCare NephroMed GmbH has informed the MHRA of the presence of an undeclared excipient in the coating of Renacet 475 mg and 950mg film-coated tablets, affecting 21 batches. This excipient is Macrogol 6000, which has always been included in Renacet

April 7th 2025

Alert: Urospir 50mg/5ml Oral Solution

One batch of Urospir 50mg/5ml Oral Solution is being recalled. The affected batch is Batch No. Expiry Date Pack Size First Distributed 1014870 30/09/2025 150ml 29/11/2024 The recall

April 2nd 2025

Alert: Utrogestan Vaginal 200mg Capsules

Uni Health Distribution Ltd is recalling six batches of Utrogestan Vaginal 200mg Capsules due to a labelling error. The carton label references ‘micrograms’ where it should actually state ‘milligrams’. The affected batch num

March 17th 2025

Alert: Promixin (colistimethate) UDVs

A national patient safety alert has been issued for Promixin (colistimethate) 1-million-unit powder for nebuliser solution unit dose vials (UDVs). These are being discontinued from early May 2025, with stocks anticipated to be exhausted by this